Authors

• Kari Bohlke (ORCID: https://orcid.org/0000-0003-1529-7903)
• Hannah D. McManus (ORCID: https://orcid.org/0000-0003-1455-2976)
• Kerri Moriarty
• Holly Anderson (ORCID: https://orcid.org/0009-0002-5435-3736)
• Kerri A. Dalton
• Gerald King
• Donald C. Moore (ORCID: https://orcid.org/0000-0001-5629-9505)
• Diane Cope
• Rebecca L. Morgan (ORCID: https://orcid.org/0000-0002-1012-4897)
• Chelsea Backler
• Karen DiValerio Gibbs (ORCID: https://orcid.org/0000-0003-4283-4241)
• Tanya Thomas (ORCID: https://orcid.org/0000-0001-7249-6568)
• Aparna Jotwani
• Caroline C. Clark (ORCID: https://orcid.org/0009-0001-3272-2054)
• Victoria Henney
• Deena Centofanti
• Celestine G. Gochett

Institutions

• Northside Hospital (US)
• Rutgers, The State University of New Jersey (US)
• University of Colorado Hospital (US)
• American Society of Clinical Oncology (US)
• Oncology Nursing Society (US)
• Duke University (US)
• Baylor College of Medicine (US)
• University of Virginia Health System (US)
• Cleveland Foundation (US)
• The Barbara Ann Karmanos Cancer Institute (US)
• Levine Cancer Institute (US)
• Babylon Breast Cancer Coalition (US)
• Florida Cancer Specialists & Research Institute (US)
• Duke Medical Center (US)
• Prostate Cancer UK (GB)
• Duke University Health System (US)
• The University of Texas Health Science Center (US)
• Case Western Reserve University (US)
• Hamilton Health Sciences (CA)
• The University of Texas Health Science Center at Houston (US)
• University of Colorado Denver (US)
• McMaster University (CA)

Publication Details

Journal

JCO Oncology Practice

Published

2025-09-18

DOI

https://doi.org/10.1200/op-25-00579

Primary Topic

Chemotherapy-related skin toxicity

Type

article

Field-Weighted Citation Impact

0.00